During the past decade, Yiyang Central Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yiyang Central Hospital" #1 sponsor was "Angde Biotech Pharmaceutical Co., Ltd." with 1 trials, followed by "CSPC ZhongQi Pharmaceutical Technology Co., Ltd." with 1 trials sponsored, "Guangdong Raynovent Biotech Co., Ltd" with 1 trials sponsored, "Jiangsu Kanion Pharmaceutical Co., Ltd" with 1 trials sponsored and "Second Xiangya Hospital of Central South University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yiyang Central Hospital" #1 collaborator was "Beijing Bionovo Medicine Development Co., Ltd." with 1 trials as a collaborator and "Beijing Tiantan Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Yiyang Central Hospital" are "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Breast Cancer" (1 trials), "Influenza A" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Yiyang Central Hospital" in a lesser frequency.

Most popular intervention types in "Yiyang Central Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Enoxaparin" (1 trials), "Injection of recombinant human tissue plasminogen kinase derivatives" (1 trials), "Mitoxantrone Hydrochloride Liposome Injection" (1 trials), "Oseltamivir(oral)" (1 trials) and "Placebo to Oseltamivir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yiyang Central Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Yiyang Central Hospital". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Yiyang Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yiyang Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".